Chargement en cours...
Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
BACKGROUND: Fingolimod, a sphingosine-1-phosphate receptor modulator with well-described immunomodulatory properties involving peripheral immune cell trafficking, was the first oral agent approved for the treatment of relapsing remitting multiple sclerosis. Analogous immunomodulatory treatment optio...
Enregistré dans:
| Publié dans: | J Neuroinflammation |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406994/ https://ncbi.nlm.nih.gov/pubmed/28446186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-0864-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|